Selectis Health, Inc.
US ˙ OTCPK

Introduction

This page provides a comprehensive analysis of the known insider trading history of Steven Mark Bathgate. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Steven Mark Bathgate has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:HQI / HireQuest, Inc. Director 27,155
US:GBCS / Selectis Health, Inc. Director 26,334
Director 0
US:PRLS / Peerless Systems Corp Director 2,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Steven Mark Bathgate. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases GBCS / Selectis Health, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in GBCS / Selectis Health, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2016-01-08 GBCS BATHGATE STEVEN MARK 13,000 0.7300 1,300 7.3000 9,490 4 0.7500 -8,515 -89.73
2014-02-20 GBCS BATHGATE STEVEN MARK 25,000 0.7500 2,500 7.5000 18,750
2013-12-31 GBCS BATHGATE STEVEN MARK 35,000 0.7500 3,500 7.5000 26,250

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GBCS / Selectis Health, Inc. Insider Trades
Insider Sales GBCS / Selectis Health, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in GBCS / Selectis Health, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GBCS / Selectis Health, Inc. Insider Trades
Insider Purchases HQI / HireQuest, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in GBCS / Selectis Health, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2018-06-22 CCNI BATHGATE STEVEN MARK 1,000 5.9000 1,000 5.9000 5,900 28 6.3000 400 6.78
2018-06-21 CCNI BATHGATE STEVEN MARK 1,071 5.5500 1,071 5.5500 5,944

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HQI / HireQuest, Inc. Insider Trades
Insider Sales HQI / HireQuest, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in GBCS / Selectis Health, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HQI / HireQuest, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Steven Mark Bathgate as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2018-10-02 2018-07-23 4 CCNI Command Center, Inc.
Common Stock
A - Award 8,025 27,155 41.95
2018-06-26 2018-06-22 4 CCNI Command Center, Inc.
Common Stock
P - Purchase 1,000 19,130 5.52 5.90 5,900 112,867
2018-06-26 2018-06-21 4 CCNI Command Center, Inc.
Common Stock
P - Purchase 1,071 18,130 6.28 5.55 5,944 100,622
2018-06-20 2018-06-18 4 CCNI Command Center, Inc.
Stock Options (right to buy)
A - Award 8,750 8,750
2018-06-12 2018-06-08 4 CCNI Command Center, Inc.
Common Stock
A - Award 2,500 17,059 17.17
2017-09-22 2017-09-20 4 CCNI Command Center, Inc.
Common Stock
A - Award 20,000 174,710 12.93
2016-08-19 3 CCNI Command Center, Inc.
Common Stock
1,949,710
2016-08-19 3 CCNI Command Center, Inc.
Common Stock
1,244,710
2016-08-19 3 CCNI Command Center, Inc.
Common Stock
1,304,420
2016-08-19 3 CCNI Command Center, Inc.
Common Stock
1,249,710
2016-08-19 3 CCNI Command Center, Inc.
Common Stock
1,949,710
2016-08-19 3 CCNI Command Center, Inc.
Common Stock
1,244,710
2016-08-19 3 CCNI Command Center, Inc.
Common Stock
1,304,420
2016-08-19 3 CCNI Command Center, Inc.
Common Stock
1,249,710
2016-05-23 2014-06-24 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Warrants
S - Sale -150,000 26,334 -85.07 0.27 -40,500 7,110
2016-01-19 2016-01-14 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
A - Award 45,455 103,788 77.92
2016-01-12 2016-01-08 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
P - Purchase 13,000 53,000 32.50 0.73 9,490 38,690
2015-01-08 2015-01-02 4 GBCS GLOBAL HEALTHCARE REIT, INC.
common stock
A - Award 33,333 58,333 133.33
2014-05-01 2014-04-30 4 GBCS GLOBAL HEALTHCARE REIT, INC.
warrants
X - Other -50,000 90,000 -35.71 0.50 -25,000 45,000
2014-05-01 2014-04-30 4 GBCS GLOBAL HEALTHCARE REIT, INC.
common stock
X - Other 50,000 748,154 7.16 0.50 25,000 374,077
2014-04-22 2014-04-14 4 GBCS GLOBAL HEALTHCARE REIT, INC.
warrants
J - Other 176,334 176,334
2014-04-22 2014-04-14 4 GBCS GLOBAL HEALTHCARE REIT, INC.
warrants
J - Other 137,404 137,404
2014-02-21 2014-02-20 4 GBCS GLOBAL HEALTHCARE REIT, INC.
common stock
P - Purchase 25,000 25,000 0.75 18,750 18,750
2014-01-06 2013-12-31 4 GBCS GLOBAL HEALTHCARE REIT, INC.
Common Stock
P - Purchase 35,000 534,113 7.01 0.75 26,250 400,585
2013-10-09 3 GBCS GLOBAL HEALTHCARE REIT, INC.
Common stock
499,113
2013-10-09 3 GBCS GLOBAL HEALTHCARE REIT, INC.
common stock
189,041
2013-08-09 2013-08-07 4 OMBP OMNI BIO PHARMACEUTICAL, INC.
Warrants (Right to Buy)
J - Other -476,000 0 -100.00
2013-08-06 2013-06-30 4 OMBP OMNI BIO PHARMACEUTICAL, INC.
Warrants (Right to Buy)
A - Award 616,000 616,000
2013-03-07 2013-03-06 4 OMBP OMNI BIO PHARMACEUTICAL, INC.
Common Stock
S - Sale -300,000 417,750 -41.80 0.25 -75,000 104,438
2013-01-03 2012-12-26 4 OMBP OMNI BIO PHARMACEUTICAL, INC.
Common Stock
P - Purchase 47,355 102,355 86.10 0.30 14,206 30,706
2013-01-03 2012-12-14 4 OMBP OMNI BIO PHARMACEUTICAL, INC.
Warrants (Right to Buy)
A - Award 10,800 10,800
2013-01-03 2012-12-14 4 OMBP OMNI BIO PHARMACEUTICAL, INC.
Warrants (Right to Buy)
A - Award 10,800 10,800
2013-01-03 2012-12-12 4 OMBP OMNI BIO PHARMACEUTICAL, INC.
Warrants (Right to Buy)
A - Award 19,124 19,124
2013-01-03 2012-12-12 4 OMBP OMNI BIO PHARMACEUTICAL, INC.
Warrants (Right to Buy)
A - Award 19,124 19,124
2013-01-03 2012-09-07 4 OMBP OMNI BIO PHARMACEUTICAL, INC.
Common Stock
J - Other -125,000 917,750 -11.99 0.25 -31,250 229,438
2013-01-03 2012-09-07 4 OMBP OMNI BIO PHARMACEUTICAL, INC.
Common Stock
P - Purchase 100,000 1,042,750 10.61 1.14 113,500 1,183,521
2012-07-02 2012-06-27 4 PRLS PEERLESS SYSTEMS CORP
Options to acquire common stock
A - Award 2,000 2,000
2012-07-02 2012-06-27 4 PRLS PEERLESS SYSTEMS CORP
Common stock
A - Award 2,577 169,875 1.54
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)